Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BTC HealthASX:BTC EV-to-EBITDA is 496.95 as of Sep. 04, 2026. The stock has 2 warning signs investors should review. Among 403 Biotechnology companies, BTC Health ranks worse than 97.52% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, BTC Health's enterprise value is A$19.88 Mil.
BTC Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was A$0.04 Mil. Therefore, BTC Health's EV-to-EBITDA for today is 496.95.
The historical rank and industry rank for BTC Health's EV-to-EBITDA or its related term are showing as below:
ASX:BTC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -53.95 Med: -24.56 Max: 505.9
Current: 496.95
During the past 13 years, the highest EV-to-EBITDA of BTC Health was 505.90. The lowest was -53.95. And the median was -24.56.
ASX:BTC's EV-to-EBITDA is ranked worse than 97.52% of 403
companies
in the Biotechnology industry
Industry Median: 13.7
vs ASX:BTC: 496.95
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
BTC Health's share price for today is A$0.06.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BTC Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was A$0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for BTC Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:BTC vs VRTX, REGN, MRNA: EV-to-EBITDA Comparison
For the Biotechnology subindustry, BTC Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BTC Health EV-to-EBITDA vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BTC Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where BTC Health's EV-to-EBITDA falls into.
BTC Health's current Enterprise Value is A$19.88 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BTC Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was A$0.04 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BTC Health (ASX:BTC) has a EV-to-EBITDA of 496.95 as of Sep. 04, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on BTC Health. According to the industry distribution chart, BTC Health ranks #393 out of 403 companies in the Biotechnology industry, placing it in the top 97.5%.
Is BTC Health's EV-to-EBITDA too high?
BTC Health's current EV-to-EBITDA is 496.95. The Biotechnology industry median EV-to-EBITDA is 13.70. BTC Health's value of 496.95 is 3527.4% above this industry median. Based on the distribution chart, BTC Health ranks #393 out of 403 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does BTC Health's EV-to-EBITDA compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BTC Health ranks #393 out of 403 companies for EV-to-EBITDA. This places BTC Health in the lower half of its industry. The industry median EV-to-EBITDA is 13.70. BTC Health's value of 496.95 is 3527.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Biotechnology company?
The median EV-to-EBITDA among Biotechnology companies is 13.70, based on 403 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BTC Health's current EV-to-EBITDA of 496.95 is 3527.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on BTC Health. For the Biotechnology industry, the median EV-to-EBITDA is 13.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BTC Health's current EV-to-EBITDA is 496.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BTC Health stock overvalued right now?
BTC Health (ASX:BTC) has a current EV-to-EBITDA of 496.95. The current EV-to-EBITDA is 496.95 and 3527.4% above the Biotechnology industry median of 13.70. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For BTC Health (ASX:BTC), the current EV-to-EBITDA is 496.95 as of Sep. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BTC Health Ltd is a pooled development fund focused on seeking new investment opportunities in entities operating in the biotechnology and life sciences sectors. Its sole operating segment involves making and managing healthcare ventures. The company's products include Elasto-Q, Rythmic Infusion Pumps, Tiva, Infusion and Nerve Catheter Kits, Biopsy Needles, Radiological Markers, Rebellion Bone Removal System, Bonopty Coaxial Bone Biopsy, ECLS (Extracorporeal Life Support) Oxygenators, Pears, Valves, NEOLA, and LPS Adsorber. Geographically, it operates in Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:BTC has been successfully added to your 
